ATH 33.3% 0.4¢ alterity therapeutics limited

he is mentioned and is on the R & D advisory board.from report...

  1. 217 Posts.
    lightbulb Created with Sketch. 3
    he is mentioned and is on the R & D advisory board.

    from report "On November 29th, 2012 the New York Academy of
    Sciences held a symposium entitled, “Targeting Metals
    in Alzheimer’s and Other Neurodegenerative Disease”.
    Featured presenters included, Dr. Rudy Tanzi, the Joseph
    P. and Rose F. Kennedy Professor of Neurology at
    Harvard University, Dr Steven Hersch of Massachusetts
    General Hospital and Harvard Medical School, Dr Dan
    Tardiff of the Whitehead Institute of Medical Research
    and Assoc. Professor Robert Cherny, Prana’s Head of
    Research. The presentations provided an in depth review
    of the role metals may play in the causative events
    leading to the neuropathology that drives Alzheimer’s
    Disease, Parkinson’s Disease and Huntington’s Disease"
 
watchlist Created with Sketch. Add ATH (ASX) to my watchlist
(20min delay)
Last
0.4¢
Change
0.001(33.3%)
Mkt cap ! $21.28M
Open High Low Value Volume
0.3¢ 0.4¢ 0.3¢ $34 10K

Buyers (Bids)

No. Vol. Price($)
28 17196248 0.3¢
 

Sellers (Offers)

Price($) Vol. No.
0.4¢ 130790145 27
View Market Depth
Last trade - 16.10pm 04/10/2024 (20 minute delay) ?
ATH (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.